Using multiplex genome engineering to overcome the constraint of positive selection, this study generates and characterizes a collection of 760 single-residue mutants encompassing the entire rifampicin binding site of *Escherichia coli* RNA polymerase (RNAP). The research identifies an alpha helix where mutations significantly enhance or disrupt rifampicin binding, leading to the discovery of mutations that convert rifampicin from bacteriostatic to bactericidal by inducing lethal DNA breaks. Additional mutations are found to increase RNAP speed, impacting nucleotide depletion, antibiotic sensitivity, and cold growth advantage. Finally, the study maps natural *rpoB* sequence diversity, revealing frequent occurrence of functional rifampicin binding site mutations in nature.
Publisher
Nature
Published On
Aug 30, 2023
Authors
Kevin B. Yang, Maria Cameranesi, Manjunath Gowder, Criseyda Martinez, Yosef Shamovsky, Vitaliy Epshtein, Zhitai Hao, Thao Nguyen, Eric Nirenstein, Ilya Shamovsky, Aviram Rasouly, Evgeny Nudler
Tags
mutants
rifampicin
RNA polymerase
bacteriostatic
antibiotic resistance
mutation impact
DNA breaks
Related Publications
Explore these studies to deepen your understanding of the subject.